|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
104.63(B) |
Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
9 |
19 |
36 |
69 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,065 |
165,412 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-16 |
4 |
D |
$7.54 |
$13,466 |
D/D |
(1,786) |
76,831 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,589 |
78,617 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-16 |
4 |
D |
$7.54 |
$14,560 |
D/D |
(1,931) |
16,145 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,122 |
18,076 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-16 |
4 |
D |
$7.54 |
$12,554 |
D/D |
(1,665) |
65,958 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,724 |
67,623 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-16 |
4 |
D |
$7.54 |
$8,068 |
D/D |
(1,070) |
70,960 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,374 |
72,030 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2013-02-16 |
4 |
D |
$7.54 |
$13,859 |
D/D |
(1,838) |
83,848 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,724 |
85,686 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-16 |
4 |
D |
$7.54 |
$7,005 |
D/D |
(929) |
69,485 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,116 |
70,414 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2013-02-16 |
4 |
D |
$7.54 |
$10,722 |
D/D |
(1,422) |
37,080 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,359 |
38,502 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-16 |
4 |
D |
$7.54 |
$29,383 |
D/D |
(3,897) |
103,757 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,471 |
107,654 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-16 |
4 |
D |
$7.54 |
$70,175 |
D/D |
(9,307) |
110,994 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,435 |
120,301 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-16 |
4 |
D |
$7.54 |
$29,564 |
D/D |
(3,921) |
67,507 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,471 |
71,428 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-16 |
4 |
D |
$7.54 |
$19,830 |
D/D |
(2,630) |
64,898 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,061 |
67,528 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-02-16 |
4 |
D |
$7.54 |
$50,201 |
D/D |
(6,658) |
157,347 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,244 |
164,005 |
|
- |
|
1831 Records found
|
|
Page 14 of 74 |
|
|